Related Experiment Video
Updated: Jan 29, 2026

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
Published on: August 25, 2014
Risks vs Benefits for SGLT2 Inhibitor Medications
Shanti Pittampalli1, Satya Upadyayula1, Hema Madhuri Mekala1
1is a Resident at Mercy Saint Vincent Medical Center in Toledo, Ohio. is a Research Scholar, and is an Emeritus Professor, both at the University of Louisville in Kentucky. is a Resident at the Griffin Memorial Hospital in Norman, Oklahoma.
Abstract:
Health care providers should carefully assess patients with diabetes mellitus before prescribing sodium-glucose cotransporter 2 inhibitor medications and monitor for adverse effects.
Related Concept Videos
Benefits of Self-Esteem
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Relative Risk
Inhaled Medications
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Endocarditis III: Medical Management

